2.38
price down icon0.21%   -0.005
pre-market  Pre-market:  2.30   -0.08   -3.36%
loading

Edesa Biotech Inc Stock (EDSA) Latest News

pulisher
Mar 13, 2025

H.C. Wainwright maintains $21 target on Edesa Biotech shares By Investing.com - Investing.com South Africa

Mar 13, 2025
pulisher
Mar 07, 2025

Edesa Biotech completes US$15 million private placement - Fasken

Mar 07, 2025
pulisher
Mar 06, 2025

Edesa Biotech files to sell 7.81M common shares for holders - MSN

Mar 06, 2025
pulisher
Mar 06, 2025

Zacks Small Cap Boosts Earnings Estimates for Edesa Biotech - Defense World

Mar 06, 2025
pulisher
Mar 03, 2025

EDSA: Raises 15 Million to Advance EB06 - Smartkarma

Mar 03, 2025
pulisher
Mar 03, 2025

EDSA: Raises $15 Million to Advance EB06… - Yahoo Finance

Mar 03, 2025
pulisher
Feb 17, 2025

Biotech Stocks To Keep An Eye OnFebruary 13th - MarketBeat

Feb 17, 2025
pulisher
Feb 15, 2025

Biotech Stocks To Keep An Eye On – February 13th - Defense World

Feb 15, 2025
pulisher
Feb 14, 2025

Edesa Biotech Reports Fiscal 1st Quarter 2025 Results - GlobeNewswire

Feb 14, 2025
pulisher
Feb 14, 2025

Edesa Biotech Advances Vitiligo Treatment Amidst Solid Financial Backing - TipRanks

Feb 14, 2025
pulisher
Feb 14, 2025

Edesa Biotech Inc. (EDSA) reports earnings - Quartz

Feb 14, 2025
pulisher
Feb 14, 2025

Edesa Biotech Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Feb 14, 2025
pulisher
Feb 14, 2025

Edesa Biotech, Inc. SEC 10-Q Report - TradingView

Feb 14, 2025
pulisher
Feb 14, 2025

Edesa Biotech Reports Q1 2025 Financial Results and Updates on EB06 Development for Vitiligo Treatment - Nasdaq

Feb 14, 2025
pulisher
Feb 14, 2025

Edesa's Q1 Report Reveals Major Vitiligo Drug Progress: $15M Cash Injection Fuels FDA Push - StockTitan

Feb 14, 2025
pulisher
Feb 14, 2025

US Penny Stocks To Watch In February 2025 - Simply Wall St

Feb 14, 2025
pulisher
Feb 14, 2025

Edesa Biotech secures $15 million for clinical program By Investing.com - Investing.com Nigeria

Feb 14, 2025
pulisher
Feb 13, 2025

Novartis to acquire Anthos Therapeutics for up to $3.1 billion - MSN

Feb 13, 2025
pulisher
Feb 13, 2025

Edesa Biotech, Inc. announced that it has received $14.999992 million in funding from Velan Capital Investment Management LP and another investor - Marketscreener.com

Feb 13, 2025
pulisher
Feb 13, 2025

H: Riding the Market Waves of Growth and Decline in 2023 - The InvestChronicle

Feb 13, 2025
pulisher
Feb 13, 2025

Edesa Biotech Inc (EDSA) Stock: A Comprehensive 52-Week Review - The InvestChronicle

Feb 13, 2025
pulisher
Feb 13, 2025

Dow Jumps Over 100 Points; Deere Posts Upbeat Earnings - Benzinga

Feb 13, 2025
pulisher
Feb 13, 2025

Stock market news: Moleculin Biotech +583.33%, Cloudastructure +105.68% among top gainers during midday trading - Business Upturn

Feb 13, 2025
pulisher
Feb 13, 2025

Nasdaq Surges 150 Points; Cisco Earnings Top Views - Benzinga

Feb 13, 2025
pulisher
Feb 13, 2025

Edesa Biotech shares jump on $15M private placement - MSN

Feb 13, 2025
pulisher
Feb 13, 2025

Edesa Biotech (EDSA) Sees Sharp Stock Increase After Equity News - Stocks Telegraph

Feb 13, 2025
pulisher
Feb 13, 2025

Stock market today: Moleculin Biotech +388.10%, Alpha Modus Holdings +156.52% among top gainers in early trading - Business Upturn

Feb 13, 2025
pulisher
Feb 13, 2025

MAXONA Pharmaceuticals Completes Phase 1 Trials for Breakthrough Pain Therapy - MSN

Feb 13, 2025
pulisher
Feb 13, 2025

US Stocks Edge Higher; Producer Prices Increase In January - Benzinga

Feb 13, 2025
pulisher
Feb 13, 2025

Truist maintains Buy on Genmab stock, price target at $50 - MSN

Feb 13, 2025
pulisher
Feb 13, 2025

Edesa Biotech announces $15 million private placement - MSN

Feb 13, 2025
pulisher
Feb 13, 2025

Information Provided Pursuant to Early Warning Requirements with Respect to Par Nijhawan and Velan Capital - Financial Post

Feb 13, 2025
pulisher
Feb 13, 2025

Edesa Biotech Announces $15.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules - Marketscreener.com

Feb 13, 2025
pulisher
Feb 13, 2025

Edesa Biotech secures $15 million for clinical program - Investing.com India

Feb 13, 2025
pulisher
Feb 13, 2025

Edesa Biotech Secures $15 Million in Private Placement to Advance Clinical Programs - TipRanks

Feb 13, 2025
pulisher
Feb 13, 2025

Edesa Biotech announces $15M private placement priced at-the-market - TipRanks

Feb 13, 2025
pulisher
Feb 13, 2025

Edesa Biotech Secures $15 Million for CXCL10 Antibody Program - TipRanks

Feb 13, 2025
pulisher
Feb 13, 2025

Edesa Biotech Announces $15.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules - GlobeNewswire

Feb 13, 2025
pulisher
Feb 13, 2025

Major Funding Alert: Edesa's $15M Deal Fuels Breakthrough Vitiligo Drug Development - StockTitan

Feb 13, 2025
pulisher
Feb 12, 2025

Dallas City Council approves planning deal for 2026 World Cup - MSN

Feb 12, 2025
pulisher
Feb 12, 2025

Mawson Finland announces private placement for up to C$5M - MSN

Feb 12, 2025
pulisher
Feb 12, 2025

Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)? - MSN

Feb 12, 2025
pulisher
Feb 05, 2025

Jabil acquires CDMO Pii to support drug development customers - MSN

Feb 05, 2025
pulisher
Jan 27, 2025

Obesity drug developer Aardvark files for IPO - MSN

Jan 27, 2025
pulisher
Jan 22, 2025

EDSA: IND Expected in 2025 for EB06 for the Treatment of Vitiligo - Research Tree

Jan 22, 2025
pulisher
Jan 22, 2025

EDSA: IND Expected in 2025 for EB06 for the Treatment of Vitiligo… - Yahoo Finance

Jan 22, 2025
pulisher
Jan 21, 2025

Edesa Biotech Announces $4.36 million Registered Direct Offering - ACCESS Newswire

Jan 21, 2025
pulisher
Jan 07, 2025

Is Raytheon the Best Defense and Aerospace Stock to Own in 2025? - The Globe and Mail

Jan 07, 2025
pulisher
Dec 27, 2024

Edesa Biotech, Inc. (NASDAQ:EDSA) Short Interest Update - Defense World

Dec 27, 2024
pulisher
Dec 20, 2024

EDSA Stock Touches 52-Week Low at $1.69 Amid Market Challenges - Investing.com

Dec 20, 2024
$75.07
price up icon 1.39%
$305.39
price down icon 0.55%
$19.19
price down icon 3.62%
$32.68
price down icon 0.52%
$97.47
price down icon 2.84%
biotechnology ONC
$254.57
price up icon 1.89%
Cap:     |  Volume (24h):